PKU HealthCare Corp Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PKU HealthCare Corp Ltd with three other
companies in this sector in China:
Yabao Pharmaceutical Group Company Limited
sales of 2.07 billion Chinese Renmimbi [US$299.25 million]
of which 80%
was Pharrmaceutical Manufacturing),
Shanxi Zhendong Pharmaceutical Co Ltd
(2.26 billion Chinese Renmimbi [US$327.78 million]
of which 95%
was Medicine Manufacture and Sale), and
Zhejiang Jianfeng Group Company Limited
(2.26 billion Chinese Renmimbi [US$327.18 million]
of which 45%
PKU HealthCare Corp Ltd reported sales of 2.01 billion Chinese Renmimbi (US$291.35 million)
December of 2015.
decrease of 11.2%
versus 2014, when the company's sales were 2.27 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 29.8% decline
in Medicine Production, from 1.03 billion Chinese Renmimbi to 723.19 million Chinese Renmimbi.
There were also decreases in sales in
Other Operation (down 12.5% to 24.67 million Chinese Renmimbi)